Search Within

Martin Stuart Tallman

  1. "2016"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (31)
Groups
  1. Adult Leukemia (64)
  2. Center for Hematologic Malignancies (64)
  3. Department of Medicine (64)
  4. Hematologic Malignancies, Division of (64)
  5. GSK Faculty (20)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (18)

More Groups

People
  1. Ross Levine (16)
  2. Sean Devlin (12)
  3. Dan Douer (10)
  4. Jae Park (9)
  5. Bartlomiej Getta (6)
  6. Eytan Stein (6)

More People

Years
  1. 2016 (64)
Publications
  1. Blood (28)
  2. Journal of Clinical Oncology (6)
  3. Haematologica (4)
  4. American Journal of Hematology (3)
  5. Bone Marrow Transplantation (2)
  6. Clinical Lymphoma, Myeloma and Leukemia (2)

More Publications

Publishers
  1. American Society of Hematology (29)
  2. American Society of Clinical Oncology (6)
  3. Nature Publishing Group (6)
  4. Ferrata Storti Foundation (4)
  5. Elsevier Inc. (3)
  6. John Wiley & Sons, Inc. (3)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TP53 mutations in AML predict adverse outcome in patients undergoing allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Getta, B. M.; Ghosh, A.; Coombs, C. C.; Devlin, S.; Arcila, M.; Mohanty, A.; Levine, R. L.; Tallman, M. S.; Jakubowski, A. A.; Giralt, S. A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplant with ablative conditioning is associated with favorable outcomes in patients with mixed phenotype acute leukemia
    Meeting Abstract

    Getta, B. M.; Zheng, J. T.; Tallman, M. S.; Park, J. H.; Stein, E. M.; Roshal, M.; Papadopoulos, E. B.; Kernan, N. A.; Steinherz, P. G.; O'Reilly, R. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Clinical relevant alterations identified by comprehensive genomic profiling can potentially improve therapeutic option and change prognosis in hematologic malignancies
    Meeting Abstract

    He, J.; Patel, M.; Phillip, I.; Bailey, M.; Berman, E.; Park, J. H.; Shukla, N. N.; Chung, S. S.; Castro-Malaspina, H.; Douer, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation is underutilized in patients with myelodysplastic syndromes
    Meeting Abstract

    Getta, B.; Kishtagari, A.; Hilden, P.; Devlin, S.; Maloy, M. A.; Gonzales, P. K.; Shaffer, B. C.; Ponce, D. M.; Gyurkocza, B.; Barker, J. N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Novel associations between mutations, prognostic and clinical parameters in untreated progressive CLL: Data from E1912, a randomized phase III study of the ECOG-ACRIN Cancer Research Group
    Meeting Abstract

    Braggio, E.; Wang, V. X.; Garcia, S.; Bruins, L. A.; Lesnick, C.; Barrientos, J. C.; O'Brien, S. M.; Tallman, M. S.; Fonseca, R.; Kay, N. E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The selective anti leukemic effect of BL-8040, a peptidic CXCR4 antagonist, is mediated by induction of leukemic blast mobilization, differentiation and apoptosis: Results of correlative studies from a Ph2a trial in acute myeloid leukemia
    Meeting Abstract

    Borthakur, G.; Tallman, M. S.; Ofran, Y.; Foran, J. M.; Uy, G. L.; DiPersio, J. F.; Nagler, A.; Rowe, J. M.; Showel, M. M.; Altman, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A distributed international patient data registry for hairy cell leukemia
    Meeting Abstract

    Andritsos, L. A.; Grever, M. R.; Anghelina, M.; Dearden, C. E.; Else, M.; Blachly, J. S.; Lele, O.; Ravandi, F.; Zent, C. S.; Johnston, J. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL
    Journal Article

    Ravandi, F.; Othus, M.; O'Brien, S. M.; Forman, S. J.; Ha, C. S.; Wong, J. Y. C.; Tallman, M. S.; Paietta, E.; Racevskis, J.; Uy, G. L.; more...
    Blood Advances (2016)

    Fulltext@MSK | Save
  • The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: Multiple myeloma, lymphoma, and acute leukemia
    Journal Article

    Boyiadzis, M.; Bishop, M. R.; Abonour, R.; Anderson, K. C.; Ansell, S. M.; Avigan, D.; Barbarotta, L.; Barrett, A. J.; Besien, K.; Bergsagel, P. L.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Final phase IIa study results evaluating the CXCR4 antagonist BL-8040 in combination with cytarabine (Ara-C) for the treatment of relapsed/refractory AML patients
    Meeting Abstract

    Borthakur, G.; Tallman, M.; Ofran, Y.; Foran, J.; Uy, G.; DiPersio, J.; Nagler, A.; Rowe, J.; Showel, M.; Altman, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save